2016 ADX
2016 ADX Banner

CONFERENCE SERIES: Biomarkers & Diagnostics

Recorded at: Next Generation Dx Summit

Digital Course: Future of Point-of-Care Platforms



2010 SC3 DVD Cover About this Product:
This digital course looks at POCT markets and technologies from the point of view of senior executives making strategic choices about priorities and market directions.  The discussion focuses on the changes in healthcare markets overall and the implications for POCT companies, especially as affected by molecular medicine.  The multiple paths to market and potential barriers for POCT firms in the changing healthcare environment are also covered, along with a range of potential strategies for success.  This course is intended for decision-makers from POCT firms and investors, as well as diagnostic firms and scientists seeking a broader business view of point-of-care.

This course answers the following questions:

  • How are diagnostic POCT markets changing?
  • Which platforms will win? What’s going to happen to the big box diagnostic companies?
  • Hospital, MD offices, or home?
  • What are the bottlenecks as markets change?
  • Where will the new markets be and how will they be organized?
  • What strategies make sense for diagnostics and POCT companies?

Course format and instructors: 

Three-hour presentation and discussion by course instructors:

  • Keith F. Batchelder, M.D., CEO, Genomic Healthcare Strategies
  • Peter S. Miller, COO, Genomic Healthcare Strategies


Keith F. Batchelder, M.D., CEO, Genomic Healthcare Strategies
Keith BatchelderKeith Batchelder is the founder and CEO of Genomic Healthcare Strategies, a company focused on the changes in healthcare resulting from advances in molecular medicine.  GHS provides strategy and implementation services for companies looking to enter or grow in the new markets emerging as result of predictive diagnostics and preventive medicine.


Peter S. Miller, COO, Genomic Healthcare Strategies 
Peter MillerPeter Miller is Chief Operating Officer of Genomic Healthcare Strategies.  He has spent his career building companies which have operated in expanding markets driven by new technology.  He has a track record of spotting trends and successful implementation.


About this Product:
2 Presentations
Over 73 Slides
107 Minutes
Individual $345
Site License $1380

About the Conference:
The Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Trends in Cancer Diagnostics, Molecular Diagnostics for Infectious Disease, and Co-Development of Drugs and Diagnostics) is designed to bring together all of the major players in the Molecular Diagnostics arena. We assemble an impressive faculty of speakers from industry, government, and the leading academic institutions.  This meeting showcases advances in technology, research and diagnostic development, with an emphasis towards application, to meet the demands of the clinic.  Plan to attend next year’s event and network with key players in the industry who are driving rapid change.

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

2016 Brochure

2016 Next Generation Dx Summit Brochure

ADX 2016 CAG Brochure Icon

Premier Sponsors


Positive ID

Precision for Medicine 

View All Sponsors

View Media Partners

Media Gallery Thumb

Related Products